Axillary Hyperhidrosis
📧 Sign up to get email alerts when something new happens for Axillary Hyperhidrosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-06-18FDA Approved: SOFDRA — Original Application (Botanix SB Inc.)
The FDA approved SOFDRA (sofpironium bromide) from Botanix SB Inc. through an original NDA for the treatment of primary axillary hyperhidros…
-
FDA approval · 2022-10-28FDA Approved: QBREXZA — Supplemental Application (Journey Medical Corporation)
The FDA approved a supplemental application for QBREXZA (glycopyrronium) filed by Journey Medical Corporation. This action updates the produ…
-
FDA approval · 2020-07-20FDA Approved: QBREXZA — Supplemental Application (Journey Medical Corporation)
The FDA approved a supplemental application for QBREXZA (glycopyrronium) submitted by Journey Medical Corporation.
-
FDA approval · 2018-06-28FDA Approved: QBREXZA — Original Application (Journey Medical Corporation)
FDA approved QBREXZA (glycopyrronium) from Journey Medical Corporation as an original NDA for the topical treatment of primary axillary hype…